Atrion

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atrion Corporation is a supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.

Gorman-Rupp

Generally speaking, small-cap stocks have market capitalizations below $2 billion. They tend to have stronger growth potential over the long run when compared to bigger companies in their respective industries.

Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth

Atrion's (ATRI) Q2 EPS drops to 23 cents, down from $3.73 year over year, as merger-related expenses with Nordson hit profits despite strong revenue growth in MPS and fluid delivery segments.

Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs

ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024.

Atrion Reports Second Quarter 2024 Results

NEW YORK , July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation

Calliditas Therapeutics AB

NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atrion Corporation (NASDAQ: ATRI)'s sale to Nordson Corporation for $460.00 per share in cash. If you are an Atrion shareholder, click here to learn more about your legal rights and options.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders

Heartland Financial USA

NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders

Nordson

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Atrion Corporation (NasdaqGS: ATRI) to Nordson Corporation (NasdaqGS: NDSN). Under the terms of the proposed transaction, shareholders of Atrion will receive $460.00 in cash for each share of Atrion that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequat.

ATRION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Atrion Corporation - ATRI

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI

NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation – ATRI

NEW YORK , July 3, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation - ATRI

Discover why Zacks gives Atrion a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Uncover ATRI's impressive growth in the medical devices market and strong financials, alongside challenges like stiff competition in the medical devices market.

Zacks Initiates Coverage of Atrion With Neutral Recommendation

NEW YORK , May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Atrion Corporation

MILWAUKEE , May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Atrion Corporation (NASDAQ: ATRI) to Nordson Corporation for $460.00 per share in cash is fair to Atrion shareholders. Halper Sadeh encourages Atrion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Atrion and i.

ATRI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Atrion Corporation Is Fair to Shareholders

ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price.

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson.

Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies

ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024.

Atrion Corporation Declares Quarterly Cash Dividend

ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024.

Atrion Reports First Quarter 2024 Results

ALLEN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2023 and the full year 2023.

Atrion Reports Fourth Quarter And Full Year 2023 Results

Atrion Corporation's share price has fallen significantly since the summer due to declining operating performance and inventory issues. The company manufactures niche medical products and has seen modest revenue growth in recent years. Despite the current challenges, the stock is trading at a more reasonable valuation, but more information is needed to assess the nature of the issues.

Atrion Corporation: A Curious But Concerning Selloff

ALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2023.

Atrion Reports Third Quarter 2023 Results

ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately.

Atrion Corporation Announces Election of New Director

Avnet

Broadridge Financial

Community Bank System

Capital Southwest

Community Trust Bancorp

Gaming and Leisure Properties

J & J Snack Foods

Altria

Schwab US Dividend Equity ETF

Service Corp

Summit Financial Group

Stock Yards Bancorp

Winnebago

Worthington Industries

The article provides insights on upcoming dividend increases, indicating strong business performance and commitment to rewarding shareholders. The list includes companies with at least five years of consistent dividend growth and higher total dividends paid out each year. The article also includes tables and metrics to help investors prioritize stocks based on yield, growth rates, and historical returns.

14 Upcoming Dividend Increases

ALLEN, Texas, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced an increase in its quarterly cash dividend from $2.15 per share to $2.20 per share. At today's meeting, the Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on September 29, 2023, to stockholders of record at the close of business on September 15, 2023.

News for Atrion Stock (ATRI)